Emcure Pharma share price jumps over 5% to 52-week high as Kotak initiates coverage with ‘Add’ rating; sees 11% upside
Emcure Pharma stock price is up more than 19% from its listing price and over 56% from its IPO price. The pharma stock has risen over 7% in one week and more than 21% in one month.